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Background
Information recall after genetic testing has been exam-
ined extensively in patients at risk for Hereditary Breast
Ovarian Cancer. We examined perceived cancer risk,
screening practices, and genetic testing-specific distress
in individuals undergoing genetic testing for Lynch
syndrome.
Methods
Individuals who underwent clinical genetic testing for
Lynch syndrome at Dana Farber Cancer Institute were
enrolled in a longitudinal questionnaire study eliciting
information on perceived cancer risk, cancer worry, can-
cer screening and health behaviors prior to testing and
after a clinical visit at which genetic test results were
disclosed. Level of genetic test specific distress was
assessed using the Multidimensional Impact of Cancer
Risk Assessment Questionnaire (MICRA), and compari-
sons between groups were made using Kruskal Wallace
non parametric analyses.
Results
129 subjects (average age 47 years) completed ques-
tionnaires, 68% were female and 53% had a personal
history of cancer. Genetic test results were classified
as: Positive for pathogenic MMR mutation (n=23,
18%), True Negative for familial MMR mutation
(n=17, 13%), Indeterminate negative (no previously
identified family mutation) (n=79, 61 %), and Variant
of uncertain significance (VUS) (n=10, 8%). 116/129
(90%) of participants correctly recalled their genetic
test result. When asked to estimate their cancer risk
compared to other people their same age, 22/23 (96%)
of individuals with a positive genetic test result cor-
rectly indicated that they were at higher risk, and 14/
17 (82%) individuals with a true negative result indi-
cated that their risk was the same as other people their
age. However, 36/79 (46%) of those with indeterminate
negative results incorrectly reported their cancer risk
was now the same or lower compared with others
their age. 111/129 (86%) of participants indicated that
they worried about cancer the same or less than before
they knew their genetic test result. Median genetic
test-specific distress scores for individuals who
received positive or VUS test results were significantly
higher compared with indeterminate negative and true
negative results (p < 0.001).
All individuals with a positive genetic test result
reported that they planned to have colorectal cancer
surveillance once a year or more frequently. Interest-
ingly, 61/79 (77%) of individuals with indeterminate
negative results and 7/17 (41 %) of those with true nega-
tive tests still planned to undergo colonoscopy screening
every 2 years or more frequently.
Conclusions
Overall, participants accurately recalled the result of
their genetic test for MMR mutations. Although some
individuals with indeterminate negative results may mis-
interpret their test result as meaning that their cancer
risk is “lower,” most plan to continue frequent colorectal
cancer surveillance. While only 8% of our cohort
received a VUS result, our findings suggest that these
patients may experience genetic test-specific distress
comparable to that of individuals who receive a positive
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© 2010 Dandapani et al; licensee BioMed Central Ltd.genetic test result. Our results suggest that post test
counseling is necessary to reinforce clinical implications
of genetic test results and recommendations for cancer
screening.
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